Intensive care admissions and outcomes associated with short-term exposure to ambient air pollution: a time series analysis. by Groves, CP et al.
Intensive Care Admissions and Outcomes Associated with Short-
Term Exposure to Ambient Air Pollution: A Time Series Analysis 
Christopher P. Groves (Department of Intensive Care, Royal North Shore Hospital, Sydney, NSW, 
Australia), Barbara K. Butland (Population Health Research Institute, St George’s, University of 
London, UK), Richard W. Atkinson (Population Health Research Institute, St George’s, University 
of London, UK), Anthony P. Delaney (Department of Intensive Care, Royal North Shore Hospital, 
NSW, Sydney, Australia), David V. Pilcher (Department of Intensive Care, Alfred Hospital, 
Melbourne, VIC, Australia. Australia and New Zealand Intensive Care Society (ANZICS) Centre for 
Outcomes and Resource Evaluation (CORE), Carlton, VIC, Australia). 
 
Authorship 
All authors contributed to study conception and design. Data collection and preparation was 
performed by CPG. Analysis was performed by BKB. The manuscript was written by CPG and all 
authors commented on previous versions of the manuscript. All authors read and approved the final 
manuscript. 
Conflict of Interest Statement 
Ms Butland owns shares in Royal Dutch Shell and Scottish and Southern Energy and her spouse has a 
deferred Shell pension. All other authors declare no conflicts of interest. 
Abstract 
Purpose 
Short-term exposure to outdoor air pollution has been positively associated with numerous 
measures of acute morbidity and mortality, most consistently as excess cardiorespiratory disease 
associated with fine particulate matter (PM2.5), particularly in vulnerable populations. It is unknown 
if the critically ill; a vulnerable population with high levels of cardiorespiratory disease, is affected by 
air pollution. 
Methods 
We performed a time series analysis of emergency cardiorespiratory, stroke and sepsis intensive 
care (ICU) admissions for the years 2008 – 2016, using data from the Australian and New Zealand 
Intensive Care Society Adult Patient Database (ANZICS-APD). Case-crossover analysis was conducted 
to assess the relationship between air pollution and the frequency and severity of ICU admissions 
having adjusted for temperature, humidity, public holidays and influenza activity. 
Results 
46,965 episodes in 87 separate ICUs were analysed. We found no statistically significant associations 
with admission counts. However, ICU admissions ending in death within 30 days were significantly 
positively associated with short-term exposure to PM2.5 (RR 1.18, 95% confidence interval (CI) 1.02 – 
1.37, per 10µg/m3 increase). This association was more pronounced in those aged 65 and over (RR 
1.33, 95% CI 1.11 – 1.58, per 10µg/m3). 
Conclusions 
Increased ICU mortality was associated with higher levels of PM2.5. Larger studies are required to 
determine if the frequency of ICU admissions is positively associated with short-term exposure to air 
pollution. 
Take Home Message 
In a large time series study of emergency ICU admissions for cardiorespiratory disease, sepsis and 
stroke, fine particulate matter air pollution (PM2.5) concentrations were significantly associated with 
an increased risk of ICU admission that ends in early death in ICU (within 30 days). This adds to 
existing observational evidence that PM2.5 is harmful to health and may lead to increased mortality 
in intensive care. 
Introduction 
Outdoor air pollution is a leading cause of death and disability worldwide, estimated to contribute to 
9 million premature deaths annually (16% of total deaths) [1], with both short- and long-term 
exposure thought harmful [2]. Air pollution is a heterogeneous mixture of gaseous, liquid and solid 
compounds, varying with locale and emission source. Conventional markers of air pollution: 
particulate matter (PM), nitrogen dioxide (NO2), ozone (O3) and sulphur dioxide (SO2) are individually 
associated with harm [3-6]. However, they are never found in isolation and the true effect is likely 
exerted by these and many other unmeasured species. 
PM has emerged as the constituent most significantly and consistently associated with harm [7]. PM 
is subcategorised as PM2.5, the mass concentration of particles with a diameter less than 2.5µm 
(‘fine’ PM), and PM10 if less than 10µm. PM2.5 is particularly associated with risks to health, observed 
1 and 3 days following exposure [8,9]. Smaller diameter is thought to confer deeper passage into the 
respiratory tree and circulatory translocation [10,11]. NO2 is usually representative of motor vehicle 
traffic and is associated with adverse outcomes in long- and short-term exposure studies [12]. 
In short-term pollution studies, increases in emergency hospital admissions and mortality have been 
found. These are mediated by excess cardiovascular, stroke and respiratory disease [9,13-15], 
particularly in susceptible populations such as the elderly [16,17]. Acute events increase within 
hours [18], with oxidative stress, pulmonary and systemic inflammation thought to result in vascular 
endothelial dysfunction, procoagulant states and autonomic dysfunction [19,20]; findings common 
in critical illness. Furthermore, patients admitted to the intensive care unit (ICU) are often elderly, 
have cardio-respiratory dysfunction and have a high risk of death and disability, suggesting they may 
be vulnerable to air pollution. There is little research on the effect of pollution on the ICU 
population, although PM and NO2 have been associated with longer mechanical ventilation [21], 
ozone and PM2.5 with an increase in acute respiratory distress syndrome [22,23], and PM2.5 with 
pneumonia-related ICU admissions [24]. It is unknown whether patients admitted to ICU when air 
pollution is increased have worse outcomes. 
Sepsis-related hospital admissions were recently associated with PM2.5 [25] and the syndrome is 
characterised by dysregulated inflammatory response to infection, sharing many features with air 
pollution exposure. In view of this and robust associations between pollution, cardiorespiratory 
disease and stroke, we hypothesised that ICU admissions for these diseases are increased, and 
adverse outcomes more common, with increased air pollution. We conducted a time series analysis 
of short-term exposure to three pollutants (PM2.5, PM10, NO2) and emergency ICU admissions in two 
Australian states: New South Wales (NSW) and Victoria. 
Methods 
Study population 
The Australia and New Zealand Intensive Care Society (ANZICS) Adult Patient Database (APD) [26] is 
one of the world’s largest ICU registries, with over 2 million episodes. Demographic, clinical and 
outcome data are submitted from over 90% of ICUs in these countries. 
Access to the APD data was granted according to standing protocol published by the ANZICS Centre 
for Outcomes and Resource Evaluation (CORE) committee [27]. The study was approved by the 
Northern Sydney Local Health District Human Research Ethics Committee (LNR/17/HAWKE/430). 
The study population and outcomes were defined a priori. Episode data were obtained on all 
unplanned, non-surgical ICU episodes in NSW and Victoria with an admission diagnosis of 
cardiorespiratory disease, stroke or sepsis (using ANZICS modification of the Acute Physiology and 
Chronic Health Evaluation (APACHE) III diagnostic codes) (S1) with initial hospital admission between 
1st January 2008 and 31st December 2016 and ICU admission occurring within 24 hours of hospital 
admission. We excluded patients under 18 years, pregnancy, and those with a residential postcode 
over 10 kilometres (km) from a pollution monitoring station. We included inter-hospital transfers but 
not transfers between ICUs to avoid double counting patients submitted to the APD twice during the 
same admission. 
Pollution Data 
Pollution data were obtained from the Environment Protection Authority of Victoria [28] and the 
Office of Environment and Heritage of NSW [29] (measurement techniques described in 
supplementary material). These are accredited by the National Association of Testing Authorities 
and conform to Australian and International standards. Stations are located away from large roads 
and industrial areas, and hence represent background pollutant levels. 
Covariate Data 
Covariates known to influence acute hospital and ICU admissions were considered. These were: 
temperature, humidity, influenza and public holidays. Meteorological data were obtained from the 
Australian Bureau of Meteorology and state-wide emergency department attendances for influenza-
like illness from the Australian Centre for Epidemiology and Evidence. Public holidays were obtained 
from public records [30]. 
Statistical analysis 
Initial data manipulation was performed using R version 3.3.3 [31]. We used residential postcode 
centroids to geographically match ICU episodes with pollution data. For each pollutant, data were 
obtained from the single monitor within a 10km radius of the postcode that provided the most 
complete time series of daily mean pollutant concentrations. Where two monitors provided the 
same amount of data, the nearest was chosen. We calculated the mean daily temperature and mean 
daily humidity for each postcode centroid over the study period based on all available 
measurements from monitoring stations within a 40km radius. 
Exposure – outcome relationships were assessed with case-crossover analysis [32]. This has become 
the standard for analysing acute events and short-term pollutant exposure (considered as a 
continuous variable). In this method, subjects serve as their own controls, reducing the effect of 
stable individual covariates. 
Strata (one for each ICU episode) were formed by matching the day of hospital admission (case day) 
with up to 4 control days, where matching was by postcode, day of the week, month and year. The 
data were then analysed using conditional logistic regression in STATA [33]. Models were run for 
each pollutant separately with the pollution data included as 3 separate variables on the admission 
day, on the day prior and two days prior (lag 0, lag 1 and lag 2). By combining the coefficients for the 
3 exposure days we obtained a summary relative risk and 95% confidence interval estimating the 
effect on ICU admission of a 10-unit (10ppb for NO2 and 10µg/m3 for particulates) increase in short-
term exposure. This representation of the pollutant is referred to as an unconstrained distributed lag 
model, lags 0-2 (UDLM 0-2). Analyses were conducted both with and without covariate adjustment. 
In the latter we adjusted for temperature and humidity lags 0-2 and 3-6 days (modelled as four 
natural cubic splines with 3 knots) (S2), influenza-like illness and public holidays. 
We investigated the associations between short-term pollutant exposure and ICU admission by 
APACHE diagnosis categories; cardiovascular, respiratory, stroke and sepsis. We then excluded 
patients admitted to ICU for palliative care or organ donation and investigated the effect of pollutant 
exposure on three measures of adverse outcome: death in ICU within 30 days; acute renal failure on 
admission to ICU (creatinine >133µmol/L and 24-hour urine output < 410ml); and invasive 
ventilation occurring within the first 24 hours of ICU admission. 
Further prespecified subgroup analyses were also performed: age divided into two groups (<65, 
≥65); admission APACHE III score (0-49, 50-99, ≥100), ICU length of stay (<7 days, 7-14 days, >14 
days) and season of admission. Missing clinical data were not used in analyses. Length of stay and 
APACHE III score were set to missing for palliative or organ donation admissions, and length of stay 
was additionally set to missing if the patient died in ICU. For 30-day ICU mortality only age and 
season were considered. Conditional logistic regression models were run with and without the 
inclusion of a potential effect modifier and any improvement in fit tested for using a likelihood ratio 
test. 
Sensitivity analyses 
Sensitivity to residual seasonality was investigated by re-running analyses with the inclusion of a 
simple sine cosine annual cycle. We investigated whether any relationship between pollutant 
exposure and the log odds of ICU admission might be non-linear by modelling pollutant means (i.e. 
the average concentration over lag days 0-2) using 3 knot natural cubic spline. Lastly, we repeated 
analyses excluding inter-hospital transfers. 
Results 
Pollutant data were obtained from 62 monitoring stations (Figure 1). Of the study period, pollution 
data were available for 75% of days for NO2, 72% for PM10 and 40% for PM2.5. Seasonal trends in daily 
mean air quality for PM10 and PM2.5, categorised according to Australian National Environment 
Protection Council Ambient Air Quality Measure (AAQ NEPM) index [34] are shown in Figure 2. 
 
Figure 1. Location of the included 62 pollution monitoring stations and associated air quality over the duration of the study. 
Each point represents the location of a single station. The fill colour represents the proportion of days with a 24 hour mean 
level of PM10, PM2.5 or NO2 classifed as "poor" or "very poor" according to the AAQ NEPM index[34]
 
 
Figure 2. Seasonal trends observed in pollutant levels. The proportion of days per month classified by AAQ NEPM index at all stations, aggregated across the study duration.
46,965 episodes in 87 separate ICUs satisfied inclusion criteria for the study. These patients were 
residents of 419 different postcodes. Data from 45 pollutant monitoring stations were used. The 
medians of daily mean pollutant concentrations were: 8 ppb (inter-quartile range (IQR) 5 to 12) for 
NO2, 6.2 µg/m3 (IQR: 4.3 to 8.8) for PM2.5 and 15.8 µg/m3 (IQR: 11.7 to 21.1) for PM10. Average within 
postcode Pearson correlation coefficients (?̅?) suggested that while daily mean concentrations of 
PM10 and PM2.5 were strongly positively correlated (?̅?= 0.694, N=291), correlations of PM10 and PM2.5 
with NO2 concentrations, though still positive, were weaker (?̅?= 0.111, N=404 and ?̅?= 0.349, N=291, 
respectively) (S3). Complete data with at least one control day was available for 36,510 ICU episodes 
for NO2, 39,039 for PM10 and 18,357 for PM2.5 (S4). In total, 40,775 individual ICU episodes were 
used in the analyses. 
For each analysis we only included episodes with complete data on the pollutant of interest and all 
covariates (i.e. the climate variables, influenza like illness activity, and public holidays) on the 
admission day and at least one control day. 
Patient characteristics 
Patient characteristics from all episodes used in analyses are summarised in Table 1. 
Characteristic n (%) or Median (IQR) 
Total ICU Episodes 40,775 
Respiratory 16,863 (41.4%) 
Cardiovascular 11,636 (28.5%) 
Sepsis 10,725 (26.3%) 
Stroke 1,551 (3.8%) 
Mortality in ICU 5,661 (13.9%) 
30-day ICU mortality 5,608 (13.8%) 
Mortality in hospital 8,093 (19.9%) 
Age (years) 67 (54 to 78) 
Male gender 22,812 (56%) 
ICU length of stay (days) 3 (1 to 5) 
Acute renal failure in first 24 hours ICU 4,127 (10.1%) 
Invasive ventilation in first 24 hours ICU 13,907 (34.2%) 
Admission APACHE III score 62 (45 to 84) 
Table 1. Patient characteristics 
Main findings 
We found PM2.5 was significantly associated with increased 30-day ICU mortality (RR 1.18, 95% CI 
1.02 – 1.37, per 10µg/m3) after adjustment for covariates (Table 2). This association was strongest 
with PM2.5 concentrations on the day of admission (S5). No significant association was found 
between mortality and PM10 or NO2. 
We found no evidence of an association between short-term exposure to NO2, PM2.5 or PM10 and ICU 
admissions (all cause or by disease subgroup), invasive ventilation or acute renal failure (Table 2). 
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All P values >0.05 except: **p=0.009 and *p=0.023 
§ Relative risks based on an unconstrained distributed lag model lags 0-2 days prior in the pollutant of interest. 
¶ Adjusted for temperature 0-2 days and 3-6 days (modelled as two natural cubic splines with 3 knots); humidity 0-2 days and 3-6 days prior (modelled as two natural cubic splines with 3 knots), flu activity 
score and public holidays. 
† Creatinine >133µmol/L and first 24-hour urine output < 410ml 
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§ Relative risks based on an unconstrained distributed lag model lags 0-2 days 
¶ Adjusted for temperature 0-2 days and 3-6 days prior (modelled as two natural cubic splines with 3 knots); humidity 0-2 days and 3-6 days prior (modelled as two natural cubic splines with 
3 knots), flu activity score and public holidays. 
‡ Patients that died in ICU excluded from analyses. 
Table 3. Subgroup analysis – relative risk of ICU admission and 30-day ICU mortality stratified by admission APACHE III score, ICU length of stay and age
Subgroup analyses 
The positive relationship between PM2.5 and 30-day ICU mortality was stronger in those aged 65 and 
over (RR 1.33, 95% CI 1.11 – 1.58, per 10µg/m3), whereas no association was found in under 65s. 
PM10 was also significantly associated with increased 30-day ICU mortality (RR 1.07, 95% CI 1.01 – 
1.14, per 10µg/m3) in the over 65s only. 
There was no modifying effect of APACHE III score or length of stay on relationships between ICU 
admission and pollutants (Table 3). We found no modifying effect of season on admission or 
mortality (S6). 
Sensitivity analyses 
Results in Table 2 were little changed by addition of a simple sine cosine annual cycle (S7), with no 
improvement in fit over a simple log-linear model for either NO2 (p=0.354), PM2.5 (p=0.261) or PM10 
(p=0.381). Lastly, we repeated analyses shown in Table 2 excluding inter-hospital transfers (S8). The 
positive association between PM2.5 and 30-day ICU mortality persisted (RR 1.19, 95% CI 1.01 – 1.41, 
per 10µg/m3), which was again driven by exposure on the day of admission. The previously observed 
negative association between risk of admission for sepsis with PM2.5 became even more negative, 
attaining statistical significance. 
Discussion 
This study is the first to investigate the relationship between air pollution, ICU admissions and 
outcome. Short-term exposure to pollution has been associated with mortality in general hospital 
populations, with additional high-risk groups identified [35]. Our study population has high mortality 
(approximately 10 to 15% [36]) and widespread organ dysfunction, the pathophysiology of which 
overlaps that described in air pollution exposure, providing a possible mechanism for interaction. 
Our results support the hypothesis that the ICU population is affected by PM2.5 and warrants further 
study. 
Our study design was informed by the strong association between pollution, cardio-respiratory 
disease and stroke. We also included sepsis based on its ubiquity in ICU, shared biological pathways 
and nascent associations with pollution [25,37]. As little is known about the effect of pollution on 
ICU population specifically, we studied only ICU admission and mortality and did not include post-
ICU hospital mortality. Previous associations have been greatest over the first few days following 
exposure, with risk returning to baseline within a week [38,39]. Our study design reflects this and 
aims to mitigate the effect of hospital-acquired pathology by including only ICU admissions within 24 
hours of hospital admission and death (in ICU) within 30 days. 
We found a statistically significant increase in 30-day ICU mortality with higher exposure to PM2.5, a 
species particularly associated with harm when co-pollutant levels are controlled for [7]. However, 
there were no statistically significant associations between pollutants and the number of ICU 
admissions, both overall and within diagnostic groups. Point estimates for PM2.5 and ICU admission 
were positive except for sepsis (Table 2), suggesting it is possible that an association exists but we 
failed to detect it as statistically significant. Larger studies are required to investigate this 
relationship further. Another possible explanation for the increased mortality without increases in 
ICU admission is that PM2.5 may exert an effect on a vulnerable cohort of ICU patients, without 
increasing ICU admission for other individuals. Increases in cardiovascular mortality without excess 
hospital admissions have been observed elsewhere [40]. 
The effect estimate on ICU admission and dying in ICU within 30 days was an 18% (95% CI 2.3% - 
36.6%) increase per 10µg/m3 increase in PM2.5. This is considerably larger than observed in general 
population studies [8,9] and may be due to the high-risk cohort we studied. This is supported by 
prespecified subgroup analysis of over 65s, in whom frailty is more common, and ICU prognosis is 
worse [41]. In this group, larger relative risk increases were found with exposure to both PM10 and 
PM2.5. This is consistent with other studies, which have shown the elderly to be particularly 
vulnerable to particulates [8,16,17]. 
PM2.5 and NO2 levels were highest in the winter months (May – August), with PM10 levels highest in 
the spring and summer (September – February), a trend observed elsewhere [42,43]. Winter is 
associated with increases in ICU mortality, traditionally ascribed to influenza and cold weather (both 
of which were controlled for in this study). Our results suggest increased PM2.5 may also contribute. 
We conducted seasonal analyses to see if outcomes were affected by annual trends (e.g. summer 
bushfires) but did not detect significant differences. 
We present relative risks per 10-unit increase in pollutant, as is standard in air pollution literature. 
Pollutant distributions were positively skewed, with low levels on most days (PM2.5 5%, 25%, 50%, 
75%, 95% percentiles: 2.3µg/m3, 4.3µg/m3, 6.2µg/m3, 8.8µg/m3, 14.4µg/m3). Toxic levels for 
pollutants are unknown, and harm has been observed even with low levels [44]. The unprecedented 
2019-20 bushfires in eastern Australia led to very high PM levels, presenting an opportunity to 
assess its impact on ICU patients. 
Weaknesses 
Short-term pollutant exposure is difficult to model, with significant variation over small areas. We 
used background monitoring station data, with a 10km allowable distance from residential postcode, 
based on similar studies [45]. Individual exposure within this radius will vary with time spent 
outdoors, proximity to pollutant sources and accumulation or dispersion due to meteorological and 
topographical factors. Our study assumes subjects have been present at their residential postcode 
prior to admission. Additionally, postcode areas are often large and eccentrically shaped, making 
centroids imprecise for matching. 
21% of our ICU episodes were inter-hospital transfers. As the time of admission to the antecedent 
hospital is not collected by the APD, transfer arrival time was used, thus exposure modelling may be 
inaccurate in these cases. They were included as most represent transfers from small rural bases to 
regional ICUs occurring within hours of presentation, but this represents a weakness in the study. In 
sensitivity analyses, when these hospital transfers were excluded, the association between PM2.5 and 
30-day mortality persisted, again driven by exposure on the day of admission. 
APD clinical data is taken only from the first 24 hours of ICU admission, hence our study was not able 
to identify outcomes after this. Furthermore, only one admission diagnosis is provided, which does 
not reflect the complexity of most ICU admissions. 
Conclusions 
We observed an association between short-term PM2.5 exposure and mortality in a large and 
heterogeneous intensive care population. This adds to observational evidence that exposure to 
particulate matter is hazardous, and that critically ill patients may have increased sensitivity to 
outdoor air pollution. Further studies are required to determine if the number of ICU admissions 
increase with higher air pollution. 
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101.01  Shock; cardiogenic  
101.02  Papillary muscle rupture  
102.01  Cardiac arrest with or without respiratory arrest; for respiratory arrest see Respiratory 
System  
103.01  Aneurysm, dissecting aortic  
104.01  Congestive heart failure  
105.01  Aneurysm/Pseudoaneurysm, other  
105.02  Thrombus, arterial  
106.01  Rhythm disturbance (primary, e.g. tachyarrhythmias, bradyarrhythymias)  
106.02  rhythm disturbance (conduction defect)  
106.03  Rhythm disturbance (atrial, supraventricular)  
106.04  Rhythm disturbance (ventricular)  
107.01  Infarction, acute myocardial (MI)  
107.02  Infarction, acute myocardial (MI), ANTERIOR  
107.03  Infarction, acute myocardial (MI), INFEROLATERAL  
107.04  Infarction, acute myocardial (MI), NON Q Wave  
107.05  Infarction, acute myocardial (MI), none of the above  
108.01  Hypertension, uncontrolled (for cerebrovascular accident see Neurological System)  
109.01  Anaphylaxis  
109.02  Angina, stable (asymptomatic or stable pattern of symptoms with meds)  
109.03  Cardiovascular medical, other  
109.04  Chest pain, atypical (non-cardiac chest pain)  
109.05  Effusion, pericardial  
109.06  Endocarditis  
109.08  Haemorrhage (for gastrointestinal bleeding see GI system, for trauma see Trauma)  
109.09  Hypovolemia (including dehydration). Do NOT include shock states  
109.10  MI admitted > 24 hr after onset of ischemia  
109.12  Pericarditis  
109.13  Tamponade, pericardial  
109.14  Thrombosis, vascular (deep vein)  
109.16  Vascular medical, other  
110.01  Cardiomyopathy  









201.01  Pneumonia, aspiration, toxic, chemical pneumonitis  
203.01  Arrest, respiratory (without cardiac arrest)  
204.01  ARDS-adult respiratory distress syndrome, non-cardiogenic pulmonary edema  
206.01  Emphysema/Bronchitis  
207.01  Embolus, pulmonary  
208.01  Obstruction-airway (e.g. acute epiglottitis, post-extubation edema, foreign body, etc.)  
209.01  Asthma  
210.01  Pneumonia, fungal  
210.02  Pneumonia, parasitic (e.g. Pneumocystis pneumonia)  
211.01  Apnea, sleep  
211.02  Atelectasis  
211.03  Effusions, pleural  
211.04  Hemorrhage/Haemoptysis, pulmonary  
211.05  Hemothorax  
211.06  Hypertension-pulmonary, primary/idiopathic  
211.08  Pneumothorax  
211.09  Respiratory-medical, other  
211.10  Restrictive lung diseases (e.g. sarcoidosis, pulmonary fibrosis)  
212.01  Pneumonia, bacterial  
212.02  Pneumonia, other  
213.01  Pneumonia, viral 





501.01  Sepsis, cutaneous/soft tissue  
501.02  Sepsis, GI  
501.03  Sepsis, gynaecologic  
501.04  Sepsis, other  
501.05  Sepsis, pulmonary  
501.06  Sepsis, unknown  
502.01  Sepsis, renal/UTI (including bladder)  
503.01  Sepsis with shock, not urinary tract  
504.01  Sepsis with shock, urinary tract  
  










101 Cardiogenic shock 
102 Cardiac arrest 
103 Aneurysm, dissecting aortic  
104 Congestive heart failure 
105 
Aneurysm/pseudoaneurysm, other  
Thrombus, arterial 
106 Rhythm disturbance 
107 Acute myocardial infarction 
108 Hypertension 
109 Other cardiovascular disease 
110 Cardiomyopathy 









201 Pneumonia, aspiration, toxic, chemical pneumonitis 
203 Respiratory arrest 
204 Pulmonary oedema – non-cardiac 
206 Chronic obstructive pulmonary disease 
207 Pulmonary embolism 
208 Mechanical airway obstruction 
209 Asthma 
210 Parasitic pneumonia 
211 Other respiratory diseases 
212 Bacterial pneumonia 
213 Viral pneumonia 




s 501 Sepsis, other than urinary 
502 Sepsis of urinary tract origin 
503 Sepsis with shock, other than urinary 
504 Sepsis of urinary tract origin with shock 
 








 101 Asthma/Allergy  
102 COPD  
103 Pulmonary oedema (non-cardiogenic)  
105 Pulmonary embolus  
106 Respiratory infection  
108 Post respiratory arrest (only)  









r 109 Hypertension  
110 Congestive cardiac failure  
112 Coronary artery disease  
114 Post cardiac arrest (only)  
115 Cardiogenic shock  
117 Rhythm disturbance  
302 Cardiovascular undefined (non-op) 
Sepsis  113 Sepsis (any aetiology)  
S1. APACHE diagnostic category inclusion criteria 
 
S2. The association between ICU admission and climate variables using 3 knot cubic splines. Dotted lines are 95% 
confidence intervals. Tests for improvement in fit over a simple log-linear model: top left p=0.739; top right p=0.263; 












Daily mean pollutant concentrations: 
No. of days (n) 1,198,528 624,775 1,265,669 1,360,010 1,354,050 
Median 8 6.2 15.8 16.25 71.70 
IQR 5 to 12 4.3 to 8.8 11.7 to 21.1 12.66 to 20.30 63.83 to 79.19 
Within post-code means: 
No. of postcodes (N) 407 301 416 415 413 
Mean 8.84 7.25 17.6 16.56 70.84 
Range 1.79 – 12.94 5.85 – 9.05 12.8 - 22.7 12.97 – 20.03 62.69 – 82.42 



















Humidity 0.168 0.038 -0.211 -0.278  
(N=402) (N=300) (N=410) (N=413) 
N=Total number of postcodes with available data (maximum: 419); n=total number of days with available data (maximum: 419x3288=1,377,672). 
S3. Summary statistics based on pollutant and climate data for 2008-2016 from 419 postcodes. 
 Pollutant No. of 
episodes 
Control days with 
complete data 
1 2 3 4 
Total ICU admissions NO2 36,510 890 5,369 19,714 10,537 
PM10 39,039 489 4,280 21,881 12,389 
PM2.5 18,357 620 2,995 9,821 4,921 
Cardiovascular admissions NO2 10,466 231 1,490 5,662 3,083 
PM10 11,162 130 1,183 6,241 3,608 
PM2.5 4,870 146 782 2,616 1,326 
Respiratory admissions NO2 15,054 364 2,189 8,141 4,360 
PM10 16,114 185 1,689 9,055 5,185 
PM2.5 7,716 262 1,230 4,114 2,110 
Stroke admissions NO2 1,376 45 223 737 371 
PM10 1,476 31 178 835 432 
PM2.5 777 26 113 456 182 
Sepsis admissions NO2 9,614 250 1,467 5,174 2,723 
PM10 10,287 143 1,230 5,750 3,164 
PM2.5 4,994 186 870 2,635 1,303 
S4. Number of episodes available for each pollutant and admission diagnosis category 
 
S5. The association between 30-day ICU mortality and exposure to PM2.5 on the day of hospital admission (lag 0), one day 
prior (lag 1) and two days prior (lag 2). (a) Unadjusted; (b) adjusted  for temperature 0-2 days and 3-6 days prior (modelled 
as two natural cubic splines with 3 knots); humidity 0-2 days and 3-6 days prior (modelled as two natural cubic splines with 
3 knots), flu activity score and public holidays; (c) as in (b) with additional adjustment for sine cosine annual cycle.
 Season 
NO2 PM2.5 PM10 
Adjusted 
RR§¶ (95% CI) 






RR§¶ (95% CI) 






RR§¶ (95% CI) 







































































§ Relative risks based on an unconstrained distributed lag model lags 0-2 days prior 
¶Adjusted for temperature 0-2 days and 3-6 days prior (modelled as two natural cubic splines with 3 knots); humidity 0-2 days and 3-6 days prior (modelled as two 
natural cubic splines with 3 knots), flu activity score and public holidays. 
S6. The effect of season on pollution and ICU admission and 30-day ICU mortality. Summer: December – March, Autumn: April – May, Winter: June – August, Spring: September – November. 
 












RR§¶ (95% CI) per 10 µg/m3 











































































§ Relative risks based on an unconstrained distributed lag model lags 0-2 days prior in the pollutant of interest. 
¶ Adjusted for temperature 0-2 days and 3-6 days prior (modelled as two natural cubic splines with 3 knots); humidity 0-2 days and 3-6 days prior (modelled as two natural cubic splines with 3 
knots), flu activity score, public holidays and a sine cosine annual cycle. 
All P values>=0.05 except: *p=0.032 
S7. Sensitivity analysis: Investigating the association between ICU admission categorised by admission diagnosis, and admission with adverse outcome after additional adjustment for 
seasonality with a sine cosine annual cycle.
 












RR§¶ (95% CI) per 10 µg/m3 































































Invasive ventilation within 










All P values >0.05 except: * p≤0.037 
§ Relative risks based on an unconstrained distributed lag model lags 0-2 days prior in the pollutant of interest. 
¶ Adjusted for temperature 0-2 days and 3-6 days (modelled as two natural cubic splines with 3 knots); humidity 0-2 days and 3-6 days prior (modelled as two natural cubic splines with 3 knots), flu activity score 
and public holidays. 
† Creatinine >133µmol/L and first 24-hour urine output < 410ml 
S8. Sensitivity analysis: relative risks of ICU admission and ICU admission with adverse outcome with inter-hospital transfers removed  
Albury Wodonga Health ICU, Alfred Hospital ICU, Austin Hospital ICU, Ballarat Health Services ICU, 
Bankstown-Lidcombe Hospital ICU, Bathurst Base Hospital ICU, Bendigo Health Care Group ICU, 
Blacktown Hospital ICU, Box Hill Hospital ICU, Cabrini Hospital ICU, Calvary Mater Newcastle ICU, 
Campbelltown Hospital ICU, Central Gippsland Health Service (Sale) ICU, Coffs Harbour Health 
Campus ICU, Concord Hospital (Sydney) ICU, Dandenong Hospital ICU, Epworth Eastern Private 
Hospital ICU, Epworth Freemasons Hospital ICU, Epworth Hospital (Richmond) ICU, Figtree Private 
Hospital ICU, Footscray Hospital ICU, Frankston Hospital ICU, Gosford Hospital ICU, Gosford Private 
Hospital ICU, Goulburn Base Hospital ICU, Goulburn Valley Health ICU, Grafton Base Hospital ICU, 
Griffith Base Hospital ICU, Hornsby Ku-ring-gai Hospital ICU, John Fawkner Hospital ICU, John Hunter 
Hospital ICU, Kareena Private Hospital ICU, Knox Private Hospital ICU, Latrobe Regional Hospital ICU, 
Lismore Base Hospital ICU, Liverpool Hospital ICU, Macquarie University Private Hospital ICU, Manly 
Hospital & Community Health ICU, Manning Rural Referral Hospital ICU, Maroondah Hospital ICU, 
Mater Private Hospital (Sydney) ICU, Melbourne Private Hospital ICU, Mildura Base Hospital ICU, 
Monash Medical Centre-Clayton Campus ICU, Mulgrave Private Hospital ICU, Nepean Hospital ICU, 
Newcastle Private Hospital ICU, North Shore Private Hospital ICU, Northeast Health Wangaratta ICU, 
Norwest Private Hospital ICU, Orange Base Hospital ICU, Peninsula Private Hospital ICU, Peter 
MacCallum Cancer Institute ICU, Port Macquarie Base Hospital ICU, Prince of Wales Hospital Sydney) 
ICU, Prince of Wales Private Hospital (Sydney) ICU, Royal Melbourne Hospital ICU, Royal Prince 
Alfred Hospital ICU, Shoalhaven Hospital ICU, South West Healthcare (Warrnambool) ICU, St George 
Hospital (Sydney) CICU, St George Hospital (Sydney) ICU, St George Hospital (Sydney) ICU2, St 
George Private Hospital (Sydney) ICU, St John of God Hospital (Bendigo) ICU, St John Of God Hospital 
(Geelong) ICU, St Vincent's Hospital (Melbourne) ICU, St Vincent's Hospital (Sydney) ICU, St Vincent's 
Private Hospital (Sydney) ICU, St Vincent's Private Hospital Fitzroy ICU, Sunshine Hospital ICU, 
Sutherland Hospital & Community Health Services ICU, Sydney Adventist Hospital ICU, Sydney 
Southwest Private Hospital ICU, Tamworth Base Hospital ICU, The Northern Hospital ICU, Tweed 
Heads District Hospital ICU, University Hospital Geelong ICU, Wagga Wagga Base Hospital & District 
Health ICU, Warringal Private Hospital ICU, Western District Health Service (Hamilton) ICU, 
Westmead Hospital ICU, Westmead Private Hospital ICU, Wimmera Health Care Group (Horsham) 
ICU, Wollongong Hospital ICU, Wollongong Private Hospital ICU, Wyong Hospital ICU 
S9. Contributing sites 
 
PM10 was measured using a Tapered Element Oscillating Microbalance (TEOM). PM2.5 was 
measured using Beta Attenuation Monitoring (BAM). 
 
